G lobal biopharmaceutical giant UCB, Inc. plans to invest $2 billion in Georgia to establish its first U.S. pharmaceutical biologics manufacturing facility. The investment will generate 330 new jobs ...

Belgium-based UCB selected Gwinnett County, Georgia, as the location for its new U.S. biologics manufacturing facility. The campus will use a digital-first approach by leveraging AI, robotics, and ...

The MarketWatch News Department was not involved in the creation of this content. -- New Gwinnett County facility will strengthen UCB's global biologics manufacturing network and support growing ...

Dan Raby, the senior digital producer for CBS News Atlanta, has been covering everything happening around Georgia for more than a decade. Global biopharmaceutical company UCB, Inc. has named Gwinnett ...

FILE - The North American headquarters of Belgian pharmaceutical company UCB is seen, Nov. 10, 2014, in Smyrna, Ga. (Paul Abell/AP Images for UCB, Inc., File) (Paul Abell) ATLANTA – Belgian ...

UCB plans to build a $2 billion manufacturing facility near its U.S. headquarters in Atlanta, Georgia. It will become the first plant in the U.S. for the Belgium-based company and will produce ...

UCB has entered the red-hot T-cell engager (TCE) space by paying $80 million for the rights to a Chinese biotech’s preclinical autoimmune candidate. At the center of the deal is ATG-201, a CD19/CD3 ...

Belgian drugmaker UCB has entered into an agreement to licence Antengene's (6996.HK), opens new tab experimental autoimmune disease therapy ATG-201 and associated ‌technology, paying $60 million up ...

After UCB’s Bimzelx scored five approvals in just two years, the Belgian drugmaker has quickly made a blockbuster out of its up-and-coming immunology powerhouse. As the first med to selectively ...

Abstract: Mobile Edge Computing (MEC) is an emerging network architecture designed to enhance Quality of Service (QoS) by bringing computational resources and storage closer to end users. In MEC ...

SAN FRANCISCO and ATLANTA, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Citizen Health today announced a new strategic partnership with UCB, a global biopharmaceutical leader in neurological and autoimmune ...